The pharmaceutical ETF is showing off again, with LLYX directly up 7% in a big rally, and Eli Lilly is also unstoppable. Inflation? What inflation? Their acquisition news caused an explosion as soon as it was released!
NVOX isn't backing down either—how many more years can the Wegovy story last?
Meanwhile, UNHG.US hit the brakes hard. Now, funds are speculating on 2x leveraged pharma ETFs—who dares to go all in? Only those with a strong heart can handle this thrill!
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
